Skanda Life Sciences

Bengaluru, India Founded: 2012 • Age: 14 yrs
Company offering drug discovery and preclinical development services

About Skanda Life Sciences

Skanda Life Sciences is a Healthcare company based in Bengaluru (India) founded in 2012. Company offering drug discovery and preclinical development services. The company has 28 employees. Its Indian entity Skanda Lifesciences Private Limited reported revenue of β‚Ή4.02 Cr. Skanda Life Sciences offers products and services including Discovery Services, Medicinal Chemistry, Analytical Chemistry, and Preclinical Development. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery.

Company details

Skanda Life sciences is a provider of integrated and collaborative drug discovery and preclinical development services to the institutions, pharmaceutical, biotech, nutraceuticals, herbals and healthcare industries. Its services include custom synthesis, analytical service, impurities, building blocks, speciality chemicals, phyto (or) herbal reference standards, cell-based assays, bioassays and immunoassays, antimicrobial , anti fungal, anti viral, PT test, Ames test and pyrogenicity. It also provides preclinical services such as ADME studies, In-Vitro and In-Vivo DMPK services, Caco2 MDCK assays etc and analytical and bioanalytical services.

Key Metrics
  • Annual Revenue
    ₹4.02 Cr

    FY 2025 · +16% YoY

  • Net Profit
    ₹36.3 Lakh

    FY 2025 · 9% margin

  • EBITDA
    ₹91.2 Lakh

    FY 2025 · 23% margin

  • Investors
  • Employee Count
    28

Products & Services of Skanda Life Sciences

Skanda Life Sciences offers a comprehensive portfolio of products and services, including Discovery Services, Medicinal Chemistry, Analytical Chemistry, and Preclinical Development.

Discovery Services
Research Services

Provides drug discovery and development processes for clients

Medicinal Chemistry
Chemical Services

Focuses on developing medicinal compounds and molecules

Analytical Chemistry
Testing Services

Offers chemical analysis for pharmaceutical applications

Preclinical Development
Development Services

Conducts in vivo and in vitro studies for drug testing

Funding Insights of Skanda Life Sciences

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Skanda Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2019Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Skanda Life Sciences

Skanda Life Sciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Startup Karnataka.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Support for startups in Karnataka is delivered through policies, funding, and networking services.
2004missionstartupkarnataka.orgBengaluru, India
Premium access

Investor details for Skanda Life Sciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Skanda Lifesciences Private Limited (Skanda Life Sciences)

Skanda Lifesciences Private Limited is the primary company behind Skanda Life Sciences. The board of Skanda Lifesciences Private Limited currently have 2 directors; the longest-serving is Swathi Shetty, appointed in 2012.

DirectorDesignationAppointedTenureEntity
Swathi Shetty
DIN 06388493
Director13 Nov 201213 yrs 11 moSkanda Lifesciences Private Limited
Shivnna Yogisha
DIN 06388499
Director13 Nov 201213 yrs 11 moSkanda Lifesciences Private Limited

Financials of Skanda Life Sciences

Figures of Skanda Lifesciences Private Limited, the primary company behind Skanda Life Sciences, for FY 2025. Revenue was ₹4.02 Cr (+16% year on year). Net profit was ₹36.3 Lakh (9% margin). EBITDA was ₹91.2 Lakh (23% margin). Revenue has grown at a compounded annual rate of +8% over three years and +19% over five years.

  • ₹4.02 CrRevenue · FY 2025 · +16% YoY
  • ₹36.3 LakhNet profit · 9% margin
  • ₹91.2 LakhEBITDA · 23% margin
  • ₹10 LakhPaid-up capital
  • 28Employees (provident fund records)
  • +8%Revenue CAGR, 3 years
  • +19%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Skanda Lifesciences Private Limited are on its company page.

Premium access

Detailed financial statements for Skanda Life Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Skanda Life Sciences

2 dated milestones of Skanda Life Sciences across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Skanda Life Sciences is founded.
  2. Funding First funding round.

Web traffic of Skanda Life Sciences

Websites that share an audience with Skanda Life Sciences (skandalifesciences.com).

Similar websites

Websites whose visitors overlap most with Skanda Life Sciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
facebook.com
100%
12.1B#3View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Skanda Life Sciences

Skanda Life Sciences was founded in 2012 and raised its 1st funding round 7 years after it was founded.

Skanda Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Skanda Life Sciences has 28 employees.

The primary company behind Skanda Life Sciences, Skanda Lifesciences Private Limited, reported revenue of β‚Ή4.02 Cr for FY 2025, up 16% year on year.

Skanda Life sciences is a provider of integrated and collaborative drug discovery and preclinical development services to the institutions, pharmaceutical, biotech, nutraceuticals, herbals and healthcare industries. Its services include custom synthesis, analytical service, impurities, building blocks, speciality chemicals, phyto (or) herbal reference standards, cell-based assays, bioassays and immunoassays, antimicrobial , anti fungal, anti viral, PT test, Ames test and pyrogenicity. It also provides preclinical services such as ADME studies, In-Vitro and In-Vivo DMPK services, Caco2 MDCK assays etc and analytical and bioanalytical services.

Skanda Life Sciences offers Discovery Services, Medicinal Chemistry, Analytical Chemistry, and Preclinical Development.

Skanda Life Sciences has 1 investor. Key investors include Startup Karnataka.

Skanda Life Sciences operates through Skanda Lifesciences Private Limited.

The legal entities of Skanda Life Sciences currently have 2 directors, including Swathi Shetty, Shivnna Yogisha.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available